Kreher et al., 2021)
Placebo and sitagliptin were used as secondary comparators to connect the network
Dehydration : Manifests as decreased urination, dark urine, dry mouth, dizziness upon standing, and fatigue Cardiovascular symptoms may occur, particularly as secondary effects of dehydration or anxiety: Increased heart rate (tachycardia) Palpitations or irregular heartbeat Lightheadedness or fainting Potential signs of pancreatitis (a rare but serious adverse effect): Severe, persistent abdominal pain, often radiating to the back Pain that worsens after eating Nausea and vomiting that doesn't resolve Tenderness when touching the abdomen Other potential symptoms include: Severe fatigue or weakness Headache Visual disturbances (if hypoglycemia develops) Altered mental status or confusion Symptom onset may begin within hours of injection but often intensifies over 1-2 days, aligning with tirzepatide's pharmacokinetic profile (peak concentration at approximately 24-48 hours)
However, metabolic syndrome is genetically determined and never goes away
2 Dose adjustments of the other diabetes medications may be necessary, and blood sugar monitoring is important for those with type 2 diabetes
Severity tracks dosing speed and individual gut sensitivity more closely than it tracks the particular molecule involved
